Neuroscientists have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression is a leading cause of disability worldwide.
Neuroscientists have developed a protein peptide that may be a novel type of highly targeted treatment for depression with a low side-effect profile. Depression is a leading cause of disability worldwide.